Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
- PMID: 18508996
- PMCID: PMC2693313
- DOI: 10.1677/ERC-07-0221
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
Abstract
Pancreatic endocrine tumors (PETs) are uncommon tumors with an annual incidence <1 per 100 000 person-years in the general population. The PETs that produce hormones resulting in symptoms are designated as functional. The majority of PETs are non-functional. Of the functional tumors, insulinomas are the most common, followed by gastrinomas. The clinical course of patients with PETs is variable and depends on the extent of the disease and the treatment rendered. Patients with completely resected tumors generally have a good prognosis, and aggressive surgical therapy in patients with advanced disease may also prolong survival. The epidemiology, prognosis, and established and novel prognostic markers of PETs are reviewed.
References
-
- Ali A, Serra S, Asa SL, Chetty R. The predictive value of CK19 and CD99 in pancreatic endocrine tumors. Am J Surg Pathol. 2006;30:1588–1594. - PubMed
-
- Barghorn A, Komminoth P, Bachmann D, Rutimann K, Saremaslani P, Muletta-Feurer S, Perren A, Roth J, Heitz PU, Speel EJ. Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression. J Pathol. 2001a;194:451–458. - PubMed
-
- Bartsch DK, Schilling T, Ramaswamy A, Gerdes B, Celik I, Wagner HJ, Simon B, Rothmund M. Management of nonfunctioning islet cell carcinomas. World J Surg. 2000;24:1418–1424. - PubMed
-
- Becker V. [Pathologicoanatomical aspects of tumors with endocrine activity] Langenbecks Arch Chir. 1971;329:426–437. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical